Riber revenues down, but orders up
Molecular beam epitaxy manufacturer, Riber, has recorded Euro 9.4 million in revenues for the first half of 2012.
Revenues for the second quarter of 2012 were down at Euro 3.2 million, compared to Euro 7.2 million for the second quarter of 2011.
However, the company states its order book has grown by 19% to Euro 21.5 million, at the end of June 2012
As Riber spokesperson, Oliver Handschumacher says, in a difficult economic climate affecting the semiconductor industry, revenue for the first half of 2012 shows a change in product mix in favour of MBE systems sales unmatched since 2002.
During the first half of 2012, the company invoiced six machines compared with three machines for the first half of 2011, and has consolidated its market positions, especially in the research sector.
In contrast, the services and accessories business is down by 15% in relation to the previous year, due, stated Riber, to a slowdown in demand in Europe and USA.
Sales of evaporation sources and cells are down compared with the first half of 2011, which included the delivery of a major investment order for OLED production equipments.
At June 30th, 2012, the breakdown of RIBER's sales was Asia (39%), Europe (37%) and North America (24%).
During the second quarter of 2012, RIBER booked four MBE system orders for research laboratories in Germany, China, France and Japan, compared with two research systems booked in the second quarter of 2011. At June 30th, 2012, the order book came to Euro 21.5 million with 16 systems to be delivered in 2012 and 2013.
The first half results and the outlook for the full year will be announced on September 19th, 2012.
